{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:13:10Z","timestamp":1790856790224,"version":"4.1.0"},"reference-count":81,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T00:00:00Z","timestamp":1163116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Risk Analysis"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:p>The history of polio vaccination in the United States spans 50 years and includes different phases of the disease, multiple vaccines, and a sustained significant commitment of resources. We estimated cost\u2010effectiveness ratios and assessed the net benefits of polio vaccination applicable at various points in time from the societal perspective and we discounted these back to appropriate points in time. We reconstructed vaccine price data from available sources and used these to retrospectively estimate the total costs of the U.S. historical polio vaccination strategies (all costs reported in year 2002 dollars). We estimate that the United States invested approximately $35 billion (1955 net present value, discount rate of 3%) in polio vaccines between 1955 and 2005 and will invest approximately $1.4 billion (1955 net present value, or $6.3 billion in 2006 net present value) between 2006 and 2015 assuming a policy of continued use of inactivated poliovirus vaccine (IPV) for routine vaccination. The historical and future investments translate into over 1.7 billion vaccinations that prevent approximately 1.1 million cases of paralytic polio and over 160,000 deaths (1955 net present values of approximately 480,000 cases and 73,000 deaths). Due to treatment cost savings, the investment implies net benefits of approximately $180 billion (1955 net present value), even without incorporating the intangible costs of suffering and death and of averted fear. Retrospectively, the U.S. investment in polio vaccination represents a highly valuable, cost\u2010saving public health program. Observed changes in the cost\u2010effectiveness ratio estimates over time suggest the need for living economic models for interventions that appropriately change with time. This article also demonstrates that estimates of cost\u2010effectiveness ratios at any single time point may fail to adequately consider the context of the investment made to date and the importance of population and other dynamics, and shows the importance of dynamic modeling.<\/jats:p>","DOI":"10.1111\/j.1539-6924.2006.00831.x","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T16:00:27Z","timestamp":1163174427000},"page":"1423-1440","source":"Crossref","is-referenced-by-count":86,"title":["Retrospective Cost\u2010Effectiveness Analyses for Polio Vaccination in the United States"],"prefix":"10.1111","volume":"26","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radboud J. Duintjer","family":"Tebbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,11,15]]},"reference":[{"key":"e_1_2_8_2_2","volume-title":"Global Polio Eradication Initiative: Progress 2003","author":"World Health Organization","year":"2004"},{"key":"e_1_2_8_3_2","unstructured":"Howard Hughes Medical Institute.FDR and Polio:Public Life Private Pain. Available at:http:\/\/www.hhmi.org\/biointeractive\/disease\/polio\/polio2.html(accessed July 17 2005)."},{"key":"e_1_2_8_4_2","volume-title":"The Cutter Incident: How America's First Polio Vaccine Led to the Growing Vaccine Crisis","author":"Offit P. A.","year":"2005"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.276.12.967"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.78.3.291"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.2001.tb00283.x"},{"key":"e_1_2_8_8_2","first-page":"340","article-title":"Polio vaccine: Should New Zealand make the change","volume":"110","author":"Baker C.","year":"1997","journal-title":"New Zealand Medical Journal"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00584-4"},{"key":"e_1_2_8_10_2","first-page":"35","article-title":"Global eradication of poliomyelitis: Benefit\u2010cost analysis","volume":"74","author":"Bart K.","year":"1996","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"e_1_2_8_11_2","first-page":"1","article-title":"Is polio eradication in the Americas economically justified?","volume":"22","author":"Musgrove P","year":"1988","journal-title":"Bulletin of the Pan American Health Organization"},{"issue":"6","key":"e_1_2_8_12_2","article-title":"The costs of polio risk management policies after eradication","volume":"26","author":"Duintjer Tebbens R. J.","year":"2006","journal-title":"Risk Analysis"},{"key":"e_1_2_8_13_2","volume-title":"OPV vs. IPV: Past and Future Choice of Vaccine in the Global Polio Eradication Program","author":"Liu X.","year":"2002"},{"issue":"1","key":"e_1_2_8_14_2","first-page":"9","article-title":"Cost analysis of post\u2010polio certification immunization policies","volume":"82","author":"Sangrujee N.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a121310"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036121"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00431-0"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.625"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220010-00001"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00437-6"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X02239651"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.10.862"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200422130-00003"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00161-3"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(96)80019-3"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00083-2"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462304001096"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(93)90094-7"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90638-X"},{"issue":"5","key":"e_1_2_8_31_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.1994.03510290057037","article-title":"Cost\u2010effectiveness of a routine varicella vaccination program for US children","volume":"271","author":"Lieu T. A.","year":"1994","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/62.1.201"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00025-7"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200321010-00002"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.50.6.667"},{"key":"e_1_2_8_36_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost\u2010Effectiveness in Health and Medicine","author":"Gold M. R.","year":"1996"},{"key":"e_1_2_8_37_2","volume-title":"Population Estimates Program, Population Division, U.S. Census Bureau","author":"U.S. Census Bureau"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200111001-00009"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00154-7"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200002000-00010"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi206"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.14.1696"},{"issue":"53","key":"e_1_2_8_43_2","first-page":"1","article-title":"Summary of notifiable diseases\u2014United States, 2000","volume":"49","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"54","key":"e_1_2_8_44_2","first-page":"12","article-title":"Annual summary 1979","volume":"28","author":"Centers for Disease Control","year":"1980","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_8_45_2","first-page":"79","article-title":"Paralytic poliomyelitis\u2014United States 1980\u20131994","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_8_46_2","volume-title":"Poliomyelitis","author":"Freyche M. J.","year":"1955"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1994.02170050037007"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.2.568"},{"key":"e_1_2_8_49_2","unstructured":"Bureau of Labor Statistics U.S. Department of Labor.Consumer Price Index. Available at:ftp:\/\/ftp.bls.gov\/pub\/special.requests\/cpi\/cpiai.txt(accessed February 2002)."},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.2307\/4590171"},{"key":"e_1_2_8_51_2","first-page":"45","volume-title":"Supplying Vaccines: An Economic Analysis of Critical Issues","author":"Sing M.","year":"1996"},{"key":"e_1_2_8_52_2","volume-title":"National Immunization Program","author":"Centers for Disease Control and Prevention","year":"2004"},{"key":"e_1_2_8_53_2","volume-title":"Epidemiology and Prevention of Vaccine\u2010Preventable Diseases (The Pink Book)","author":"Centers for Disease Control and Prevention","year":"2003"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.2307\/4593032"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.2307\/4591594"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00433-9"},{"issue":"5","key":"e_1_2_8_57_2","first-page":"396","article-title":"Cost study of poliomyelitis vaccine injections","volume":"72","author":"Anonymous","year":"1957","journal-title":"Public Health Reports"},{"key":"e_1_2_8_58_2","volume-title":"A Cost Benefit Analysis of the OPV Vaccine","author":"Hatzandrieu E. J.","year":"1994"},{"key":"e_1_2_8_59_2","volume-title":"Office of Information and Regulatory Affairs","author":"Office of Management and Budget","year":"2003"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.5.1158"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114471"},{"issue":"4","key":"e_1_2_8_62_2","first-page":"35","article-title":"Policy decision options during the first 5 years following certification of polio eradication","volume":"5","author":"Sangrujee N.","year":"2003","journal-title":"Medscape General Medicine"},{"issue":"6","key":"e_1_2_8_63_2","article-title":"Risks of paralytic disease due to wild or vaccine\u2010derived poliovirus after eradication","volume":"26","author":"Duintjer Tebbens R. J.","year":"2006","journal-title":"Risk Analysis"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.066043"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/jmedent\/13.1.1"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059040-00001"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.30875\/6c788b5e-en"},{"issue":"1","key":"e_1_2_8_68_2","first-page":"16","article-title":"Circulating vaccine\u2010derived polioviruses: Current state of knowledge","volume":"82","author":"Kew O. M.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"issue":"45","key":"e_1_2_8_69_2","first-page":"401","article-title":"Conclusions and recommendations of the ad hoc advisory committee on poliomyelitis eradication, Geneva, 21\u201322 September 2004","volume":"79","author":"World Health Organization","year":"2004","journal-title":"Weekly Epidemiological Record"},{"key":"e_1_2_8_70_2","volume-title":"Global Eradication of Poliomyelitis by the Year 2000 (Resolution 41.28)","author":"World Health Assembly","year":"1988"},{"key":"e_1_2_8_71_2","volume-title":"Poliomyelitis","author":"Debr\u00e9 R.","year":"1955"},{"key":"e_1_2_8_72_2","first-page":"651","volume-title":"Vaccines","author":"Sutter R. W.","year":"2004"},{"key":"e_1_2_8_73_2","volume-title":"Transmissibility and Persistence of Oral Poliovirus Vaccine Viruses: Implications for the Global Poliomyelitis Eradication Initiative","author":"Fine P. E. M.","year":"1998"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S165"},{"key":"e_1_2_8_75_2","volume-title":"Historical Statistics of the United States, Colonial Times to 1970","author":"U.S. Bureau of the Census","year":"1975"},{"key":"e_1_2_8_76_2","unstructured":"U.S. Census Bureau. (1999).U.S. Census Bureau Statistical Abstract of the United States. Washington DC : U.S. Department of Commerce . Available at:http:\/\/www.census.gov\/prod\/www\/statistical\u2010abstract\u2010us.html(accessed June 2 2004)."},{"key":"e_1_2_8_77_2","unstructured":"U.S. Census Bureau. (2000).U.S. Census Bureau Statistical Abstract of the United States. Washington DC : U.S. Department of Commerce . Available at:http:\/\/www.census.gov\/prod\/www\/statistical\u2010abstract\u2010us.html(accessed June 2 2004)."},{"key":"e_1_2_8_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(01)00286-0"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.271.11.833"},{"key":"e_1_2_8_80_2","first-page":"1","article-title":"An evaluation of the 1954 poliomyelitis vaccine trials. Summary report","volume":"45","author":"Francis T.","year":"1955","journal-title":"American Journal of Public Health"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1086\/321905"},{"key":"e_1_2_8_82_2","unstructured":"UN Population Division.World Population Prospects Population Database: The 2002 Revision Population Database. Available at:http:\/\/esa.un.org\/unpp\/index.asp?panel=2(accessed July 31 2003)."}],"container-title":["Risk Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1539-6924.2006.00831.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1539-6924.2006.00831.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1539-6924.2006.00831.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1539-6924.2006.00831.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1539-6924.2006.00831.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T07:19:28Z","timestamp":1707376768000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1539-6924.2006.00831.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,15]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1111\/j.1539-6924.2006.00831.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1539-6924.2006.00831.x","archive":["Portico"],"relation":{},"ISSN":["0272-4332","1539-6924"],"issn-type":[{"value":"0272-4332","type":"print"},{"value":"1539-6924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,15]]}}}